Loading data
VMDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 270.28 m USD | 224.26 m USD | 183.01 m USD | 138.83 m USD | 117.06 m USD |
| Cost of revenue | 114.82 m USD | 91.05 m USD | 70.23 m USD | 54.15 m USD | 43.65 m USD |
| Gross profit | 155.46 m USD | 133.2 m USD | 112.78 m USD | 84.68 m USD | 73.41 m USD |
| Research and development expense | 3.02 m USD | 3.07 m USD | 2.78 m USD | 2.7 m USD | 2.11 m USD |
| Selling, general and administrative expense | 121.37 m USD | 106.2 m USD | 87.88 m USD | 68.16 m USD | 54.89 m USD |
| Operating profit | 22.95 m USD | 17.9 m USD | 14.33 m USD | 8.25 m USD | 11.58 m USD |
| Profit before tax | 21.77 m USD | 16.17 m USD | 14.39 m USD | 8.99 m USD | 12.5 m USD |
| Income tax expense | 6.39 m USD | 4.76 m USD | 4.15 m USD | 2.77 m USD | 3.38 m USD |
| Net income (reported basis) | 15.38 m USD | 11.41 m USD | 10.24 m USD | 6.22 m USD | 9.13 m USD |
| Basic earnings per share | 0.38 USD/share | 0.29 USD/share | 0.27 USD/share | 0.16 USD/share | 0.23 USD/share |
| Diluted earnings per share | 0.37 USD/share | 0.28 USD/share | 0.25 USD/share | 0.16 USD/share | 0.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.